For Year 2025-26, Onesource Specialty Pharma reports the following shareholding: Total Promoters at 29.93%, Mutual Fund at 9.02%, Insurance at 2.53%, Foreign Institutional Investors at 19.24%, Domestic Institutional Investors at 7.13%, and Retail at 32.15%. This breakdown provides a quick snapshot of ownership distribution for Onesource Specialty Pharma in 2025-26.